Ultralife Stock Price, News & Analysis

Ultralife Corporation (NASDAQ: ULBI) has scheduled its first quarter 2025 financial results announcement for May 9, 2025, before market opening. The results will cover the period ended March 31, 2025.

The company will host an investor conference call and simultaneous webcast at 10:00 AM ET on the same day. To ensure smooth participation, attendees joining by phone must pre-register through a provided link to receive dial-in information and a personal identification number.

Investors can access the live webcast through the Events & Presentations section on Ultralife's website. For those unable to attend live, a replay will be available shortly after the call at the same location.

Ultralife (NASDAQ: ULBI) reported Q4 2024 results with sales of $43.9 million, slightly down from $44.5 million in Q4 2023. The quarter saw an 11.7% increase in Battery & Energy Products sales but a 55.1% decrease in Communications Systems sales.

Key Q4 metrics include gross profit of $10.6 million (24.2% margin), operating income of $1.5 million (including $1.1 million in Electrochem acquisition costs), and GAAP EPS of $0.01. The company completed the acquisition of Electrochem on October 31, 2024, contributing $6.1 million to revenue.

For full-year 2024, sales reached $164.5 million, a 3.7% increase year-over-year, with operating income of $10.0 million and GAAP EPS of $0.38. The company's backlog and high confidence orders stood at $102.2 million exiting 2024, up from $78.0 million in Q3.

Ultralife (NASDAQ: ULBI) has announced it will release its fourth quarter results for the period ending December 31, 2024, before market opens on Tuesday, April 1, 2025. The company's management will host an investor conference call and simultaneous webcast at 8:30 AM ET on the same day.

Participants joining by phone must pre-register through a provided link to ensure reliable connection. A live webcast will be accessible through the Events & Presentations section of Ultralife's website, with a replay available shortly after the call.

Ultralife (NASDAQ: ULBI) has filed a Form 12b-25 with the SEC, notifying a delay in submitting its Annual Report on Form 10-K for fiscal year 2024. The delay is attributed to the ongoing completion of accounting close and financial results audit of Electrochem Solutions, Inc., which was acquired on October 31, 2024.

The company expects to file its Form 10-K no later than April 1, 2025. Consequently, Ultralife will reschedule its previously planned fourth quarter and fiscal year 2024 earnings release and conference call from March 11, 2025. The new date will be announced once the Form 10-K filing date is confirmed.

Ultralife (NASDAQ: ULBI) has scheduled its fourth quarter 2024 financial results release for March 11, 2025, before market opening. The delayed reporting timeline, later than the company's usual practice of reporting in the sixth week after year-end, is attributed to additional time needed to complete the accounting close and audit of Electrochem Solutions, Inc., which was acquired on October 31, 2024.

Management will host an investor conference call and webcast at 8:30 AM ET on the same day. Participants joining by phone must pre-register through a provided link to ensure reliable connection. A live webcast will be available on the company's website, with a replay accessible shortly after the call.

Ultralife (NASDAQ: ULBI) has announced two key executive appointments effective January 6, 2025. Jeffrey Luke joins as Chief Marketing Officer, tasked with reframing corporate and brand strategies while ensuring global alignment. Luke brings over 20 years of B2B marketing experience across various industries.

James Pope has been appointed Senior Vice President - Sales & Business Development, Battery & Energy Products, bringing 37 years of battery and power industry experience. Pope will focus on market expansion and aligning global sales efforts to maximize revenue and build strategic partnerships.

CEO Mike Manna emphasized these appointments are important for commercializing transformational products and executing the company's long-term growth strategy. The expanded leadership team aims to enhance new product development, strengthen customer relationships, and capitalize on growth opportunities.

Ultralife (NASDAQ:ULBI) has announced its participation in The Benchmark Company's 13th Annual Discovery One-on-One Investor Conference. The event is scheduled for Wednesday, December 11th, 2024 at the New York Athletic Club in New York City.

The conference provides a unique platform for emerging growth and dynamic publicly traded companies to connect with institutional and individual investors in an exclusive one-on-one format. Throughout the day, Ultralife will engage in direct meetings with investors and analysts. Interested parties can schedule meetings through the provided registration link.

Ultralife (NASDAQ: ULBI) reported Q3 2024 results with sales of $35.7 million, down from $39.5 million in Q3 2023. The Battery & Energy Products segment saw 1.9% growth, while Communications Systems sales decreased 58.2%. Gross profit was $8.7 million (24.3% margin), compared to $9.8 million (24.8%) last year. Operating income decreased to $0.5 million from $2.1 million, including $0.3 million in acquisition-related costs. GAAP EPS fell to $0.02 from $0.08. The company reduced debt by $4.1 million to $8.0 million, representing a 68.2% reduction over two quarters.

Ultralife (NASDAQ: ULBI) has completed the acquisition of Electrochem Solutions for $50.0 million in cash from Integer Holdings Based in Raynham, MA, Electrochem specializes in primary lithium metal and ultracapacitor cells and battery packs, serving energy, military, and environmental markets globally. The acquired company generated revenue of $34 million for the trailing twelve months ended September 30, 2024. The transaction was financed through a new Credit and Security Agreement with KeyBank, N.A., M&T Bank, and Community Bank as lenders.